The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

The obe­si­ty drug race is be­ing fought on the man­u­fac­tur­ing floor as GLP-1 ri­vals make plans to catch lead­ers

11 months ago
Pharma
In Focus

Ag­i­lent Tech­nolo­gies to ac­quire CD­MO Biovec­tra for $925M

11 months ago
Deals

Catal­ent fin­ish­es Ger­man ex­pan­sion; Grü­nen­thal in­vests in Latin Amer­i­ca 

12 months ago

Sanofi seeks deep­er roots in In­dia with €400M hub ex­pan­sion

12 months ago

In­vest­ment firm launch­es with $100M for bio­pro­cess­ing en­tre­pre­neurs  

12 months ago
Financing

FDA warns Chi­nese drug­mak­er for se­ri­ous GMP record vi­o­la­tions

12 months ago
FDA+

Cor­den­Phar­ma in­jects €900M to boost GLP-1 man­u­fac­tur­ing in US and Eu­rope

12 months ago

J&J and Emer­gent set­tle Covid con­tract dis­pute; Siegfried names new CEO

Last year

FDA re­jects No­vo Nordisk’s once-week­ly in­sulin af­ter ques­tion­ing risks

Last year
FDA+

No­vo-part­nered 3D bio­print­ing biotech gets $70M+ from Cana­di­an gov­ern­ment

Last year
Financing

House com­mit­tee rais­es con­cerns on CDER-CBER mis­align­ment amid 2025 fund­ing markup

Last year
FDA+

Avid Bio’s 2024 rev­enue drops; Lotte Bio breaks ground on new $3.3B site 

Last year

As con­fi­dence falls, bio­phar­ma com­pa­nies take pre­cau­tions with Chi­nese part­ner­ships, sur­vey finds

Last year
China
Outsourcing

Sam­sung Bio pulls in $1.06B man­u­fac­tur­ing deal with un­named US phar­ma com­pa­ny

Last year
Deals

FDA says can­cer drug cis­platin is no longer in short­age

Last year
Pharma
FDA+

UniQure sells Mass­a­chu­setts man­u­fac­tur­ing site to Genezen as it con­tin­ues to down­size

Last year
Deals

Rovi teas­es ac­qui­si­tion of­fers for its CD­MO unit po­ten­tial­ly worth €2B to €3B

Last year
Deals
Pharma

FDA re­jects Rock­et Phar­ma’s ul­tra-rare im­mune dis­ease gene ther­a­py over man­u­fac­tur­ing

Last year
Cell/Gene Tx
FDA+

GSK’s man­u­fac­tur­ing sites in Sin­ga­pore will use 100% re­new­able en­er­gy by 2025 

Last year

SK Bio­science takes ma­jor­i­ty stake in CD­MO for $244M; Ex-Lon­za CEO joins Cy­ti­va

Last year

Eu­roAPI over­haul comes in­to fo­cus with plans to cut 550 staffers and di­vest two fa­cil­i­ties 

Last year

EMA calls for mem­ber states to lend a hand to ease GLP-1 sup­ply bot­tle­necks

Last year
Pharma

FDA again re­jects Ab­b­Vie's con­tin­u­ous in­fu­sion ther­a­py for Parkin­son's

Last year
Pharma
FDA+

House com­mit­tee press­es FDA on signs of in­con­sis­tent in­spec­tions in Chi­na and In­dia

Last year
FDA+
First page Previous page 11121314151617 Next page Last page
A service from the Financial Times